Loading clinical trials...
Loading clinical trials...
Precision Medicine in the Prostate Cancer Care Pathway: an Evaluation of Integrating Germline Genetic Testing Into the Management of Men at Risk of / Living With Prostate Cancer
Conditions
Interventions
Prostate cancer risk gene panel
Locations
1
United Kingdom
Royal Marsden Hosital,
Sutton, England, United Kingdom
Start Date
February 14, 2019
Primary Completion Date
December 31, 2029
Completion Date
December 1, 2034
Last Updated
December 16, 2025
NCT06594926
NCT06257264
NCT03620786
NCT05939414
NCT05424783
NCT04693377
Lead Sponsor
Institute of Cancer Research, United Kingdom
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions